AREV NanoTec Engages QNR Associates to Advise on Filing Health Canada Product Applications and Closes Private Placement

VANCOUVER, BC – TheNewswire - January 6, 2021 - AREV NANOTEC BRANDS INC. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV Brands”) is pleased to announce that it has retained the services of QNR Associates to consult on regulatory matters including filing Natural Product License registrations with Health Canada for the company’s proprietary product formulations and a Dealer License.

Further, the Company has closed the 1,000,000 unit, non brokered, Private Placement Unit Offering to raise a total of $100,000 with one strategic investor. Each Unit is priced at $0.10 per unit and comprised of one common share (the “Shares”) of the Company and one common share purchase warrant (each whole one, the “Warrants”) and with each Warrant being exercisable at $0.15 per Warrant Share. Subject to adjustment in certain events, each whole Warrant entitles the holder thereof to purchase one additional common share (the “Warrant Shares”) of the Company at any time on or before 5:00 p.m. (Vancouver time) on the date that is 12 months from the date of issuance of the Warrants.

The funds will be used for general working capital.

The company is also pleased to announce it has retained Winning Media LLC ("Winning"), of Houston Texas, to provide strategic digital media services, marketing, and data analytics services in the United States. Winning will be paid a fee of US$100,000 for a one-month contract. Neither Winning nor any representatives of Winning own any securities of AREV directly or indirectly or have any intention to acquire any securities of AREV.

Mr. Mike Withrow reports that Chiron Capital Inc. (“Chiron”), a company that Mr. Withrow controls, has acquired ownership, control, and direction over 1,000,000 common shares (the “Shares”) of AREV Nanotec Brands Inc. (the “Company”). The Shares were acquired pursuant to the exercise of warrants. As a result of the acquisition of the Shares, Mr. Withrow controls, and Chiron owns, 11,003,000 Shares representing approximately 52% of the issued and outstanding Shares. Chiron has acquired the securities for investment purposes and, may in the future acquire or dispose of securities of the Company, through the market, privately or otherwise, as circumstances or market conditions warrant. Mr. Withrow and Chiron are accredited investors as defined in NI 45-106.

For further information, contact Mike Withrow, 778-929-6536.

On behalf of the Board,

Mike Withrow
CEO & Director

About AREV NanoTec Inc.  
AREV NanoTec Brands Inc. (“AREV”) produces and sells functional ingredients produced via its proprietary extraction systems. These premium ingredients and products are targeted for the natural health, medical, functional food, nutraceutical, sport nutrition markets. AREV’s model is to toll process extraction of targeted essential and functional oils and license its formulations to Licensed Producers in Canada.  The company utilizes toll processors in foreign countries to encapsulate and package its formulations that can be sold in traditional distribution channels and online.



Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, and continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws. This press release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements.  Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company’s Management’s Discussion and Analysis under the Company’s profile on   

Copyright (c) 2021 TheNewswire - All rights reserved.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.